{"transactions":[{"id":767741,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-21T20:13:02.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":10539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2027 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":10539,"derivative":{"exercise_price":5.08,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":10539},"source":{"system":"sec-edgar","filing":"0001303811-26-000002","document":"form4-05212026_080558.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000130381126000002/form4-05212026_080558.xml","form_type":"4"}},{"id":1129111,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-30T23:26:39.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":143789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2026 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":143789,"derivative":{"exercise_price":0.3598,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":143789},"source":{"system":"sec-edgar","filing":"0001415889-25-015054","document":"form4-05302025_110528.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000141588925015054/form4-05302025_110528.xml","form_type":"4"}},{"id":1227575,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2025-03-05T01:19:57.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":508,"price":42.92,"value":21803.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":264730,"source":{"system":"sec-edgar","filing":"0000950170-25-032802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017025032802/ownership.xml","form_type":"4"}},{"id":1227574,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2025-03-05T01:19:57.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":6028,"price":42.1,"value":253778.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.77 to $42.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":265238,"source":{"system":"sec-edgar","filing":"0000950170-25-032802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017025032802/ownership.xml","form_type":"4"}},{"id":1227573,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2025-03-05T01:19:57.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":18443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric."}],"balance_after":271266,"source":{"system":"sec-edgar","filing":"0000950170-25-032802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017025032802/ownership.xml","form_type":"4"}},{"id":1394096,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-02T20:35:20.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":174139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning on October 10, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":174139,"derivative":{"exercise_price":0.7,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":174139},"source":{"system":"sec-edgar","filing":"0001415889-24-024416","document":"form4-10022024_081016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000141588924024416/form4-10022024_081016.xml","form_type":"4"}},{"id":1580840,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2024-03-12T17:41:05.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":11509,"price":49.93,"value":574644.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.92 to $50.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":252823,"source":{"system":"sec-edgar","filing":"0000950170-24-029780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017024029780/ownership.xml","form_type":"4"}},{"id":1595184,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T01:19:45.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":31400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":31400,"derivative":{"exercise_price":53.69,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":31400},"source":{"system":"sec-edgar","filing":"0000950170-24-026661","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017024026661/ownership.xml","form_type":"4"}},{"id":1595183,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2024-03-06T01:19:45.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":1011,"price":53.76,"value":54351.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":264332,"source":{"system":"sec-edgar","filing":"0000950170-24-026661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017024026661/ownership.xml","form_type":"4"}},{"id":1595182,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2024-03-06T01:19:45.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":274,"price":53.69,"value":14711.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":265343,"source":{"system":"sec-edgar","filing":"0000950170-24-026661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017024026661/ownership.xml","form_type":"4"}},{"id":1595181,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2024-03-06T01:19:45.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric."}],"balance_after":265617,"source":{"system":"sec-edgar","filing":"0000950170-24-026661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017024026661/ownership.xml","form_type":"4"}},{"id":1595180,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2024-03-06T01:19:45.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":17800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"}],"balance_after":264660,"source":{"system":"sec-edgar","filing":"0000950170-24-026661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000095017024026661/ownership.xml","form_type":"4"}},{"id":1755649,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-24T21:22:48.000Z","date":"2023-10-23","kind":"exercise","planned":true,"acquired":false,"shares":39878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":6.86,"expiration_date":"2023-10-31","underlying":"Common Stock","underlying_shares":39878},"source":{"system":"sec-edgar","filing":"0001209191-23-053487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123053487/doc4.xml","form_type":"4"}},{"id":1755648,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2023-10-24T21:22:48.000Z","date":"2023-10-23","kind":"sale","planned":true,"acquired":false,"shares":39878,"price":32.78,"value":1307200.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $33.18 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":246860,"source":{"system":"sec-edgar","filing":"0001209191-23-053487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123053487/doc4.xml","form_type":"4"}},{"id":1755647,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2023-10-24T21:22:48.000Z","date":"2023-10-23","kind":"exercise","planned":true,"acquired":true,"shares":39878,"price":6.86,"value":273563.08,"ownership":{"direct":true},"balance_after":286738,"source":{"system":"sec-edgar","filing":"0001209191-23-053487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123053487/doc4.xml","form_type":"4"}},{"id":1972640,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-04T00:57:33.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":39400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":39400,"derivative":{"exercise_price":45.65,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":39400},"source":{"system":"sec-edgar","filing":"0001209191-23-016046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123016046/doc4.xml","form_type":"4"}},{"id":1972639,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2023-03-04T00:57:33.000Z","date":"2023-03-01","kind":"disposition_to_issuer","acquired":false,"shares":3394,"price":45.65,"value":154936.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":246860,"source":{"system":"sec-edgar","filing":"0001209191-23-016046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123016046/doc4.xml","form_type":"4"}},{"id":1972638,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2023-03-04T00:57:33.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1968,"price":45.27,"value":89091.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":250254,"source":{"system":"sec-edgar","filing":"0001209191-23-016046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123016046/doc4.xml","form_type":"4"}},{"id":1972637,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2023-03-04T00:57:33.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":252222,"source":{"system":"sec-edgar","filing":"0001209191-23-016046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123016046/doc4.xml","form_type":"4"}},{"id":1972636,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2023-03-04T00:57:33.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":2663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric."}],"balance_after":230222,"source":{"system":"sec-edgar","filing":"0001209191-23-016046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919123016046/doc4.xml","form_type":"4"}},{"id":2333100,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2022-03-15T20:33:10.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":10281,"price":67.01,"value":688929.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":227559,"source":{"system":"sec-edgar","filing":"0001209191-22-018829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919122018829/doc4.xml","form_type":"4"}},{"id":2353686,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T23:07:44.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":24900,"derivative":{"exercise_price":67.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0001209191-22-015806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919122015806/doc4.xml","form_type":"4"}},{"id":2353685,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2022-03-03T23:07:44.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":227840,"source":{"system":"sec-edgar","filing":"0001209191-22-015806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919122015806/doc4.xml","form_type":"4"}},{"id":2353684,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2022-03-03T23:07:44.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":2374,"price":66.62,"value":158155.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."}],"balance_after":213840,"source":{"system":"sec-edgar","filing":"0001209191-22-015806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919122015806/doc4.xml","form_type":"4"}},{"id":2419087,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2022-02-01T18:42:43.000Z","date":"2021-12-10","kind":"gift","acquired":false,"shares":52,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":216214,"source":{"system":"sec-edgar","filing":"0001209191-22-005840","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919122005840/doc5.xml","form_type":"5"}},{"id":2540436,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2021-10-18T22:48:23.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":286,"price":81.14,"value":23206.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":216266,"source":{"system":"sec-edgar","filing":"0001209191-21-060754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121060754/doc4.xml","form_type":"4"}},{"id":2554224,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-01T16:57:51.000Z","date":"2021-09-30","kind":"exercise","acquired":false,"shares":109734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0.31,"expiration_date":"2021-11-17","underlying":"Common Stock","underlying_shares":109734},"source":{"system":"sec-edgar","filing":"0001209191-21-058365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121058365/doc4.xml","form_type":"4"}},{"id":2554223,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2021-10-01T16:57:51.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":109734,"price":0.31,"value":34017.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":216552,"source":{"system":"sec-edgar","filing":"0001209191-21-058365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121058365/doc4.xml","form_type":"4"}},{"id":2720732,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2021-05-10T22:11:59.000Z","date":"2021-05-06","kind":"sale","acquired":false,"shares":363,"price":113.69,"value":41269.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":106818,"source":{"system":"sec-edgar","filing":"0001209191-21-031384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121031384/doc4.xml","form_type":"4"}},{"id":2812512,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T01:55:51.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":11000,"derivative":{"exercise_price":142.47,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-21-017567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121017567/doc4.xml","form_type":"4"}},{"id":2812511,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2021-03-04T01:55:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":4572,"price":138.17,"value":631713.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.16 to $138.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 139 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2020."}],"balance_after":107181,"source":{"system":"sec-edgar","filing":"0001209191-21-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121017567/doc4.xml","form_type":"4"}},{"id":2812510,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2021-03-04T01:55:51.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":4636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 1,530 shares of common stock and 3,106 RSUs into which previously granted performance stock units were converted on March 1, 2021 upon certification of the performance metric. The RSUs will fully vest on March 1, 2022."}],"balance_after":111614,"source":{"system":"sec-edgar","filing":"0001209191-21-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121017567/doc4.xml","form_type":"4"}},{"id":2812509,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2021-03-04T01:55:51.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":106978,"source":{"system":"sec-edgar","filing":"0001209191-21-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919121017567/doc4.xml","form_type":"4"}},{"id":3005067,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2020-10-16T23:20:49.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":262,"price":87.98,"value":23050.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":101478,"source":{"system":"sec-edgar","filing":"0001209191-20-055178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120055178/doc4.xml","form_type":"4"}},{"id":3123697,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2020-06-03T18:18:51.000Z","date":"2020-06-01","kind":"tax_withholding","acquired":false,"shares":348,"price":69.38,"value":24144.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 413 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2020."}],"balance_after":101740,"source":{"system":"sec-edgar","filing":"0001209191-20-033884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120033884/doc4.xml","form_type":"4"}},{"id":3156217,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2020-05-09T00:04:32.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":248,"price":66.26,"value":16432.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":101675,"source":{"system":"sec-edgar","filing":"0001209191-20-028112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120028112/doc4.xml","form_type":"4"}},{"id":3172320,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2020-04-21T19:35:50.000Z","date":"2020-04-19","kind":"tax_withholding","acquired":false,"shares":248,"price":58.57,"value":14525.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":101923,"source":{"system":"sec-edgar","filing":"0001209191-20-025190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120025190/doc4.xml","form_type":"4"}},{"id":3231689,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T00:47:47.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":20000,"derivative":{"exercise_price":56.08,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-015739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120015739/doc4.xml","form_type":"4"}},{"id":3231688,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2020-03-04T00:47:47.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":2067,"price":56.08,"value":115917.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 129 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2019."}],"balance_after":102171,"source":{"system":"sec-edgar","filing":"0001209191-20-015739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120015739/doc4.xml","form_type":"4"}},{"id":3231687,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2020-03-04T00:47:47.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":5634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 1,859 shares of common stock and 3,775 RSUs into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":104109,"source":{"system":"sec-edgar","filing":"0001209191-20-015739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120015739/doc4.xml","form_type":"4"}},{"id":3231686,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2020-03-04T00:47:47.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":98475,"source":{"system":"sec-edgar","filing":"0001209191-20-015739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919120015739/doc4.xml","form_type":"4"}},{"id":3392835,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-10-16T23:29:14.000Z","date":"2019-10-14","kind":"grant","acquired":true,"shares":1434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":91675,"source":{"system":"sec-edgar","filing":"0001209191-19-053325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119053325/doc4.xml","form_type":"4"}},{"id":3502078,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-06-04T22:56:33.000Z","date":"2019-06-01","kind":"tax_withholding","acquired":false,"shares":346,"price":54.93,"value":19005.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":90241,"source":{"system":"sec-edgar","filing":"0001209191-19-034548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119034548/doc4.xml","form_type":"4"}},{"id":3515017,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-05-22T21:41:53.000Z","date":"2019-05-21","kind":"tax_withholding","acquired":false,"shares":381,"price":59.5,"value":22669.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":90587,"source":{"system":"sec-edgar","filing":"0001209191-19-032135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119032135/doc4.xml","form_type":"4"}},{"id":3536390,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-05-07T22:50:19.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":1434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on May 6, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 308 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2019."}],"balance_after":90968,"source":{"system":"sec-edgar","filing":"0001209191-19-028087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119028087/doc4.xml","form_type":"4"}},{"id":3551037,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-04-23T22:20:48.000Z","date":"2019-04-19","kind":"tax_withholding","acquired":false,"shares":248,"price":64.43,"value":15978.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":89226,"source":{"system":"sec-edgar","filing":"0001209191-19-025609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119025609/doc4.xml","form_type":"4"}},{"id":3553556,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T22:05:35.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":21500,"derivative":{"exercise_price":67.55,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-19-025125","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119025125/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-04"}},{"id":3553555,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-04-17T22:05:35.000Z","date":"2019-03-05","kind":"sale","acquired":false,"shares":832,"price":65.52,"value":54512.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units."}],"balance_after":89474,"source":{"system":"sec-edgar","filing":"0001209191-19-025125","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119025125/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-04"}},{"id":3553554,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-04-17T22:05:35.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 191 shares acquired under the Company's 2014 Employee Stock Purchase Plan."}],"balance_after":90306,"source":{"system":"sec-edgar","filing":"0001209191-19-025125","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119025125/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-04"}},{"id":3618697,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-04T22:05:43.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":21500,"derivative":{"exercise_price":67.55,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-19-015736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119015736/doc4.xml","form_type":"4"}},{"id":3618696,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-03-04T22:05:43.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":806,"price":67.55,"value":54445.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":89499,"source":{"system":"sec-edgar","filing":"0001209191-19-015736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119015736/doc4.xml","form_type":"4"}},{"id":3618695,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2019-03-04T22:05:43.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 191 shares acquired under the Company's 2014 Employee Stock Purchase Plan."}],"balance_after":90305,"source":{"system":"sec-edgar","filing":"0001209191-19-015736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919119015736/doc4.xml","form_type":"4"}},{"id":3908079,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2018-06-04T20:48:24.000Z","date":"2018-06-01","kind":"tax_withholding","acquired":false,"shares":346,"price":73.73,"value":25510.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":83114,"source":{"system":"sec-edgar","filing":"0001209191-18-035172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919118035172/doc4.xml","form_type":"4"}},{"id":3921879,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2018-05-22T15:46:04.000Z","date":"2018-05-21","kind":"tax_withholding","acquired":false,"shares":381,"price":64.79,"value":24684.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 312 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2018."}],"balance_after":83460,"source":{"system":"sec-edgar","filing":"0001209191-18-032211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919118032211/doc4.xml","form_type":"4"}},{"id":3959992,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2018-04-19T20:45:23.000Z","date":"2018-04-19","kind":"grant","acquired":true,"shares":1431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on April 19, 2018 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":83529,"source":{"system":"sec-edgar","filing":"0001209191-18-025591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919118025591/doc4.xml","form_type":"4"}},{"id":4014631,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T21:16:23.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":30000,"derivative":{"exercise_price":48.43,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-016415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919118016415/doc4.xml","form_type":"4"}},{"id":4014630,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2018-03-05T21:16:23.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":307,"price":48.43,"value":14868.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":82098,"source":{"system":"sec-edgar","filing":"0001209191-18-016415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919118016415/doc4.xml","form_type":"4"}},{"id":4014629,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2018-03-05T21:16:23.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 177 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2017."}],"balance_after":82405,"source":{"system":"sec-edgar","filing":"0001209191-18-016415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919118016415/doc4.xml","form_type":"4"}},{"id":4297932,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2017-06-02T01:12:22.000Z","date":"2017-06-01","kind":"tax_withholding","acquired":false,"shares":376,"price":56.61,"value":21285.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units."}],"balance_after":76228,"source":{"system":"sec-edgar","filing":"0001209191-17-036971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919117036971/doc4.xml","form_type":"4"}},{"id":4309868,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2017-05-22T22:59:58.000Z","date":"2017-05-21","kind":"tax_withholding","acquired":false,"shares":414,"price":57.47,"value":23792.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 228 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 28, 2017."}],"balance_after":76604,"source":{"system":"sec-edgar","filing":"0001209191-17-034484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919117034484/doc4.xml","form_type":"4"}},{"id":4413717,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-01T22:47:50.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":25000,"derivative":{"exercise_price":88.8,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-016073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919117016073/doc4.xml","form_type":"4"}},{"id":4413716,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":45188,"kind":"person","name":"Kassberg Thomas Richard","position":1,"cik":"0001303811","reported_name":"Kassberg Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & EVP"}}],"security":"Common Stock","published_at":"2017-03-01T22:47:50.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":76790,"source":{"system":"sec-edgar","filing":"0001209191-17-016073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303811/000120919117016073/doc4.xml","form_type":"4"}}]}